Diamond, J. R., Standifer, N., Ascierto, M. L., Morehouse, C., Ghadially, H., Rodriguez Canales, J., Rebelatto, M. C., Naidoo, J., Mazzarella, L., Patel, S., Flor Oncala, M. J., Alonso Gordoa, T., Wang, D., Song, X., Jones, D. C., Li, X., Marshall, S., Abdullah, S., Jure-Kunkel, M., & Hellmann, M. D. (n.d.). 1194PTranslational endpoints in patients with metastatic microsatellite-stable colorectal cancer (MSS-CRC) treated with durvalumab plus monalizumab (anti-NKG2A). Annals of oncology, 29, . http://access.bl.uk/ark:/81055/vdc_100095510076.0x00003b